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Background
Sialorrhea or hypersalivation is an uncomfortable adverse
effect of antipsychotics. Salivary flow is predominantly
under parasympathetic control, whereas the sympathetic
system has a minor modifying effect in the saliva compo-
sition. However, the mechanism by which atypical antip-
sychotics cause hypersalivation remains controversial.
We report the case of a patient with risperidone-induced
sialorrhea that responded well to I.M. administration of
biperiden.
Materials and methods
The patient was an 18 year old female suffering from
schizophrenia, paranoid type. She had no history of any
medical condition. The onset of her psychiatric condition
was at the age of 17. Due to low adherence, she had never
taken any medications and had no previous hospitaliza-
tions. During her hospitalization, she was started on 1mg/
d lorazepam and 2mg/d risperidone (with a gradual
increase up to 6mg/d on day 3, due to lack of response
and progressive thought disorganization). On day 4 the
patient exhibited hypersalivation and a concomitant mild
speech disturbance. No signs of EPS where present except
for mildly impaired postural reflexes that could be consid-
ered as a sign of imminent EPS. Subsequently, risperidone
was tapered to 3mg/d along with oral biperiden 2mg/d
resulting to full remission of hypersalivation by day 5.
Results
Excessive salivation remains a paradoxical adverse effect
of antipsychotic treatment possibly due to the antimus-
carinic properties of several antipsychotics. The mecha-
nisms proposed include a postsynaptic a-adrenergic-
mediated, by blockade of the a-adrenoreceptors at the
level of salivary glands, a cholinergic-specific M4 receptor
stimulation and an abnormal deglutition by blockade of
receptors in the pharynx or in the muscles involved in the
swallowing reflex.
In our case, hypersalivation could be attributed to esopha-
geal dysfunction, as an EPS, however there was no evi-
dence of EPS. Moreover, sialorrhea occurred with
risperidone that has no reported affinity for muscarinic
receptors. The most likely mechanism seems to be
through central a-adrenergic antagonism, since risperi-
done is a potent antagonist of a1 and a2-adrenoreceptors.
On the other hand, biperiden probably reversed sialor-
rhea by re-establishing the adrenergic-cholinergic balance
through muscarinic receptor blockade.
To our knowledge this is the first case report of a risperi-
done-induced sialorrhea responsive to biperiden adminis-
tration. The data about the efficacy of anticholinergics in
the treatment of antipsychotic-induced hypersalivation
remain controversial suggesting the need for further inves-
tigation.
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